Clinical and Psychometric Distinction of Frontotemporal and Alzheimer Dementias

Authors:

Abstract
Frontotemporal lobar degeneration (FTLD) represents a group of disorders that is considered to be clinically and pathologically distinct from Alzheimer disease (AD),1 although FTLD may be mistaken for AD in the early clinical stages.2,3 Based on clinicopathological consensus criteria,4 the FTLDs are classified into 3 groups. One group is represented by the tauopathies, characterized by inclusions containing aggregates of the microtubule-associated protein τ: Pick disease, corticobasal degeneration, progressive supranuclear palsy, tangle-only dementia, argyrophilic grain disease, and familial cases with τ mutations, also called frontotemporal dementia with parkinsonism linked to chromosome 17. Another group, which represents most cases of FTLD, is characterized by ubiquitin-positive τ-negative inclusions, FTLD with motor neuron disease–type inclusions, or inclusion body myositis with Paget disease and frontotemporal dementia. The final group represents cases with no detectable inclusions, generically called FTLD or dementia lacking distinctive histopathological features.